Eton Pharmaceuticals Files 8-K on Shareholder Votes
Ticker: ETON · Form: 8-K · Filed: Jun 10, 2025 · CIK: 1710340
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing
TL;DR
Eton Pharma filed an 8-K on June 10th about shareholder votes. All good.
AI Summary
Eton Pharmaceuticals, Inc. filed an 8-K on June 10, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31). It also provides contact information for the company's principal executive offices located in Deer Park, Illinois.
Why It Matters
This filing informs shareholders about important corporate actions and decisions that require their input, impacting the company's governance and strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not appear to contain significant new financial or operational risks.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Registrant
- June 10, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Deer Park, Illinois (location) — Principal Executive Offices
- 001-38738 (other) — Commission File Number
FAQ
What specific matters were submitted to a vote of Eton Pharmaceuticals' security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 10, 2025.
In which state is Eton Pharmaceuticals, Inc. incorporated?
Eton Pharmaceuticals, Inc. is incorporated in Delaware.
What is the business address of Eton Pharmaceuticals, Inc.?
The business address is 21925 W. Field Parkway, Suite 235, Deer Park, Illinois 60010-7278.
What is the telephone number for Eton Pharmaceuticals, Inc.?
The telephone number is (847) 787-7361.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).